(EXPD) Expeditors International of - Overview
Sector: IndustrialsIndustry: Integrated Freight & Logistics | Exchange NYSE (USA) | Currency USD | Market Cap: 19.614m | Total Return 21.2% in 12m
Stock: Freight Forwarding, Customs Brokerage, Warehousing, Transportation
Total Rating 65
Risk 85
Buy Signal -0.07
| Risk 5d forecast | |
|---|---|
| Volatility | 25.5% |
| Relative Tail Risk | -9.28% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.62 |
| Alpha | 12.64 |
| Character TTM | |
|---|---|
| Beta | 0.564 |
| Beta Downside | 0.938 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.26% |
| CAGR/Max DD | 0.54 |
EPS (Earnings per Share)
Revenue
Description: EXPD Expeditors International of March 05, 2026
Expeditors International of Washington, Inc. (EXPD) is a global logistics company. It offers airfreight, ocean freight, and customs brokerage services.
The company operates as a third-party logistics (3PL) provider, managing supply chains for other businesses without owning the transport assets. This model allows for flexibility in scaling operations based on client demand.
EXPD provides a range of services including warehousing, distribution, and specialized solutions like temperature-controlled transit and cargo insurance. The logistics sector is integral to global trade, facilitating the movement of goods across borders.
For more detailed financial analysis and performance metrics, consider exploring ValueRay.
Headlines to watch out for
- Global trade volume directly impacts freight forwarding demand
- Air and ocean freight rates dictate revenue and profitability
- Customs regulations and compliance costs influence operations
- Geopolitical stability affects supply chain disruptions and demand
- Fuel price volatility impacts transportation costs and margins
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 810.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.19 > 0.02 and ΔFCF/TA 5.12 > 1.0 |
| NWC/Revenue: 15.20% < 20% (prev 15.03%; Δ 0.17% < -1%) |
| CFO/TA 0.21 > 3% & CFO 1.01b > Net Income 810.8m |
| Net Debt (-284.0m) to EBITDA (1.14b): -0.25 < 3 |
| Current Ratio: 1.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (134.6m) vs 12m ago -3.83% < -2% |
| Gross Margin: 14.85% > 18% (prev 0.13%; Δ 1.47k% > 0.5%) |
| Asset Turnover: 229.5% > 50% (prev 223.0%; Δ 6.50% > 0%) |
| Interest Coverage Ratio: -104.5 > 6 (EBITDA TTM 1.14b / Interest Expense TTM -10.4m) |
Altman Z'' 6.43
| A: 0.34 (Total Current Assets 3.76b - Total Current Liabilities 2.07b) / Total Assets 4.89b |
| B: 0.52 (Retained Earnings 2.54b / Total Assets 4.89b) |
| C: 0.22 (EBIT TTM 1.08b / Avg Total Assets 4.82b) |
| D: 0.93 (Book Value of Equity 2.36b / Total Liabilities 2.53b) |
| Altman-Z'' Score: 6.43 = AAA |
Beneish M -3.01
| DSRI: 0.97 (Receivables 2.02b/2.00b, Revenue 11.07b/10.60b) |
| GMI: 0.86 (GM 14.85% / 12.73%) |
| AQI: 1.30 (AQ_t 0.03 / AQ_t-1 0.02) |
| SGI: 1.04 (Revenue 11.07b / 10.60b) |
| TATA: -0.04 (NI 810.8m - CFO 1.01b) / TA 4.89b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of EXPD shares?
As of March 27, 2026, the stock is trading at USD 142.66 with a total of 721,258 shares traded.
Over the past week, the price has changed by -3.11%, over one month by -1.42%, over three months by -6.29% and over the past year by +21.17%.
Over the past week, the price has changed by -3.11%, over one month by -1.42%, over three months by -6.29% and over the past year by +21.17%.
Is EXPD a buy, sell or hold?
Expeditors International of has received a consensus analysts rating of 2.44.
Therefor, it is recommend to sell EXPD.
- StrongBuy: 0
- Buy: 0
- Hold: 10
- Sell: 3
- StrongSell: 3
What are the forecasts/targets for the EXPD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 139.3 | -2.4% |
| Analysts Target Price | 139.3 | -2.4% |
EXPD Fundamental Data Overview March 23, 2026
P/E Trailing = 24.5554
P/E Forward = 24.3902
P/S = 1.772
P/B = 8.2943
P/EG = 3.8384
Revenue TTM = 11.07b USD
EBIT TTM = 1.08b USD
EBITDA TTM = 1.14b USD
Long Term Debt = 570.6m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 110.9m USD (from shortTermDebt, last quarter)
Debt = 1.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -284.0m USD (from netDebt column, last quarter)
Enterprise Value = 19.33b USD (19.61b + Debt 1.03b - CCE 1.31b)
Interest Coverage Ratio = -104.5 (Ebit TTM 1.08b / Interest Expense TTM -10.4m)
EV/FCF = 20.27x (Enterprise Value 19.33b / FCF TTM 953.4m)
FCF Yield = 4.93% (FCF TTM 953.4m / Enterprise Value 19.33b)
FCF Margin = 8.61% (FCF TTM 953.4m / Revenue TTM 11.07b)
Net Margin = 7.33% (Net Income TTM 810.8m / Revenue TTM 11.07b)
Gross Margin = 14.85% ((Revenue TTM 11.07b - Cost of Revenue TTM 9.42b) / Revenue TTM)
Gross Margin QoQ = 14.47% (prev 16.05%)
Tobins Q-Ratio = 3.95 (Enterprise Value 19.33b / Total Assets 4.89b)
Interest Expense / Debt = 0.02% (Interest Expense 159k / Debt 1.03b)
Taxrate = 23.31% (61.1m / 262.0m)
NOPAT = 831.1m (EBIT 1.08b * (1 - 23.31%))
Current Ratio = 1.81 (Total Current Assets 3.76b / Total Current Liabilities 2.07b)
Debt / Equity = 0.44 (Debt 1.03b / totalStockholderEquity, last quarter 2.36b)
Debt / EBITDA = -0.25 (Net Debt -284.0m / EBITDA 1.14b)
Debt / FCF = -0.30 (Net Debt -284.0m / FCF TTM 953.4m)
Total Stockholder Equity = 2.28b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.81% (Net Income 810.8m / Total Assets 4.89b)
RoE = 35.57% (Net Income TTM 810.8m / Total Stockholder Equity 2.28b)
RoCE = 38.03% (EBIT 1.08b / Capital Employed (Equity 2.28b + L.T.Debt 570.6m))
RoIC = 36.46% (NOPAT 831.1m / Invested Capital 2.28b)
WACC = 7.56% (E(19.61b)/V(20.64b) * Re(7.96%) + D(1.03b)/V(20.64b) * Rd(0.02%) * (1-Tc(0.23)))
Discount Rate = 7.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.94%
[DCF] Terminal Value 78.72% ; FCFF base≈845.2m ; Y1≈767.7m ; Y5≈671.9m
[DCF] Fair Price = 102.4 (EV 13.38b - Net Debt -284.0m = Equity 13.66b / Shares 133.5m; r=7.56% [WACC]; 5y FCF grow -11.42% → 3.0% )
EPS Correlation: -23.02 | EPS CAGR: -8.16% | SUE: 0.54 | # QB: 0
Revenue Correlation: -49.97 | Revenue CAGR: -12.26% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.46 | Chg7d=+0.011 | Chg30d=-0.027 | Revisions Net=-1 | Analysts=11
EPS current Year (2026-12-31): EPS=6.06 | Chg7d=+0.021 | Chg30d=+0.011 | Revisions Net=+3 | Growth EPS=+1.8% | Growth Revenue=+1.2%
EPS next Year (2027-12-31): EPS=6.54 | Chg7d=+0.000 | Chg30d=+0.041 | Revisions Net=+0 | Growth EPS=+7.9% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: -0.20 (2 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.9% (Discount Rate 8.0% - Earnings Yield 4.1%)
[Growth] Growth Spread = -1.7% (Analyst 2.2% - Implied 3.9%)
P/E Forward = 24.3902
P/S = 1.772
P/B = 8.2943
P/EG = 3.8384
Revenue TTM = 11.07b USD
EBIT TTM = 1.08b USD
EBITDA TTM = 1.14b USD
Long Term Debt = 570.6m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 110.9m USD (from shortTermDebt, last quarter)
Debt = 1.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -284.0m USD (from netDebt column, last quarter)
Enterprise Value = 19.33b USD (19.61b + Debt 1.03b - CCE 1.31b)
Interest Coverage Ratio = -104.5 (Ebit TTM 1.08b / Interest Expense TTM -10.4m)
EV/FCF = 20.27x (Enterprise Value 19.33b / FCF TTM 953.4m)
FCF Yield = 4.93% (FCF TTM 953.4m / Enterprise Value 19.33b)
FCF Margin = 8.61% (FCF TTM 953.4m / Revenue TTM 11.07b)
Net Margin = 7.33% (Net Income TTM 810.8m / Revenue TTM 11.07b)
Gross Margin = 14.85% ((Revenue TTM 11.07b - Cost of Revenue TTM 9.42b) / Revenue TTM)
Gross Margin QoQ = 14.47% (prev 16.05%)
Tobins Q-Ratio = 3.95 (Enterprise Value 19.33b / Total Assets 4.89b)
Interest Expense / Debt = 0.02% (Interest Expense 159k / Debt 1.03b)
Taxrate = 23.31% (61.1m / 262.0m)
NOPAT = 831.1m (EBIT 1.08b * (1 - 23.31%))
Current Ratio = 1.81 (Total Current Assets 3.76b / Total Current Liabilities 2.07b)
Debt / Equity = 0.44 (Debt 1.03b / totalStockholderEquity, last quarter 2.36b)
Debt / EBITDA = -0.25 (Net Debt -284.0m / EBITDA 1.14b)
Debt / FCF = -0.30 (Net Debt -284.0m / FCF TTM 953.4m)
Total Stockholder Equity = 2.28b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.81% (Net Income 810.8m / Total Assets 4.89b)
RoE = 35.57% (Net Income TTM 810.8m / Total Stockholder Equity 2.28b)
RoCE = 38.03% (EBIT 1.08b / Capital Employed (Equity 2.28b + L.T.Debt 570.6m))
RoIC = 36.46% (NOPAT 831.1m / Invested Capital 2.28b)
WACC = 7.56% (E(19.61b)/V(20.64b) * Re(7.96%) + D(1.03b)/V(20.64b) * Rd(0.02%) * (1-Tc(0.23)))
Discount Rate = 7.96% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.94%
[DCF] Terminal Value 78.72% ; FCFF base≈845.2m ; Y1≈767.7m ; Y5≈671.9m
[DCF] Fair Price = 102.4 (EV 13.38b - Net Debt -284.0m = Equity 13.66b / Shares 133.5m; r=7.56% [WACC]; 5y FCF grow -11.42% → 3.0% )
EPS Correlation: -23.02 | EPS CAGR: -8.16% | SUE: 0.54 | # QB: 0
Revenue Correlation: -49.97 | Revenue CAGR: -12.26% | SUE: 0.22 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.46 | Chg7d=+0.011 | Chg30d=-0.027 | Revisions Net=-1 | Analysts=11
EPS current Year (2026-12-31): EPS=6.06 | Chg7d=+0.021 | Chg30d=+0.011 | Revisions Net=+3 | Growth EPS=+1.8% | Growth Revenue=+1.2%
EPS next Year (2027-12-31): EPS=6.54 | Chg7d=+0.000 | Chg30d=+0.041 | Revisions Net=+0 | Growth EPS=+7.9% | Growth Revenue=+4.0%
[Analyst] Revisions Ratio: -0.20 (2 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.9% (Discount Rate 8.0% - Earnings Yield 4.1%)
[Growth] Growth Spread = -1.7% (Analyst 2.2% - Implied 3.9%)